UPDATE: BTIG Research Initiates Coverage On Histogenics On NeoCart Potential
January 23, 2015 at 10:02 AM EST
In a report published Friday, BTIG Research analyst Sean Lavin initiated coverage on Histogenics Corp. (NASDAQ: HSGX) with a Buy rating ...
